Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950103-17-010811
Filing Date
2017-11-03
Accepted
2017-11-03 15:08:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 17129
2 GRAPHIC image_003.jpg GRAPHIC 2382
  Complete submission text file 0000950103-17-010811.txt   21497
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)